Jhanavi Sharma and Rohan Kumar conducted a COVID-19 serosurvey funded by Genotypic Technology Pvt. Ltd., to ensure that vaccines were effectively producing antibodies in the subjects.
Image
Unique URL
/student-project/jhanavi-sharma-rohan-kumar-na
Components
Banner Items
Title
COVAT study to the serological response of the Indian cohort in Uttarakhand
Image
Tag
School of Health Sciences and Technology
Mobile Image
Description
Jhanavi Sharma and Rohan Kumar
HTML Content
Jhanavi Sharma, Rohan Kumar, students pursuing the degree of MSc. In Microbiology &, Integrated- BSc-MSc during their tenure in 2021 conducted their project on a cross-sectional coronavirus vaccine-induced antibody test (COVAT study) to the serological response of the Indian cohort in Uttarakhand
A COVID-19 serosurvey jointly funded by Genotypic Technology pvt limited and UPES R&D was conducted on May 3 and 4, 2023, at UPES campus to ensure that vaccines have effectively produced antibodies in the subjects. India was recording thousands of cases, and awareness of whether the vaccine had induced an antibody response would have made people decide whether to go for a booster. The vaccines are ineffective against all isolates, but they help reduce the viral load and severity of the disease.
The project was conducted by a serosurvey funded by Genotypic technology pvt. Ltd.
Html Type
Detail Content
Gallery Type
Imae Gallery
Items
Interior Image
Exterior Image
Mentor List
Weight
0